LSM-775 Facts
Psychedelic;
Description
LSM-775 (lysergic acid morpholide) is a synthetic psychedelic of the lysergamide class. It activates serotonin receptors in two opposing ways — generating and simultaneously suppressing psychedelic signals — producing a body-heavy, muted result.[1][2]
Subjective effects include nausea, sedation, mild geometric visual patterns, mood shifts, and pervasive bodily heaviness. The experience is defined by somatic weight — a nauseogenic, heavy baseline through which faint perceptual changes emerge, less a psychedelic journey than a body burden with psychedelic undertones.[3]
LSM-775 produces no physical dependence, and no lethal dose has been established — rapid tolerance makes compulsive redosing self-limiting.[4] The dominant hazard is the pronounced body load: severe nausea, vomiting, and cardiovascular stress at effective doses, plus a theoretical risk of heart valve damage with repeated use.[1]
Dose and durationby route · individual sensitivity varies
Starts in 10 – 30 minLasts 6 – 10 hoursAfter-effects 2 – 6 hours
Body and dependence
- Acute toxicity
- Low
- Chronic toxicity
- Low
- Physical dependence
- None
- Psychological dependence
- Negligible
- Withdrawal
- None recorded
- Compulsive redosing
- Negligible
Tolerance
- Builds
- Rapid
- Fully resets after
- 14 days
- Carries over to
- LSD;
psilocybin; mescaline; DMT; other lysergamides
Effectslikely at a common dose
- Perception
- none likely · 36 possible, including Visual haze / noise, Spatial disorientation, Vestibular distortion
- Body
- Pupil dilation;
Body high; Body scan awareness; +33 possible, including Nausea, Muscle tension, Heart rate perception changes - Thinking
- none likely · 33 possible, including Thought loops, Confusion, Cognitive impairment
- Feeling
- none likely · 9 possible, including Emotional lability, Anxiety, Paranoia
- Self
- none likely · 10 possible, including Derealization, Depersonalization
- Time
- Time alteration;
+3 possible, including Temporal disorientation - Transpersonal
- none likely · 1 possible
- Awareness
- none likely · 5 possible
Who shouldn't take it
Combinations61 recorded
Seek help immediately if
Most difficulty is psychological (intense fear, panic, confusion) and passes with calm support — the signs below mean seek emergency help:
- Very high body temperature; hot, dry skin
- Seizures
- Chest pain; fast or irregular heartbeat
- Severe muscle rigidity, tremor, or twitching (possible serotonin syndrome)
- Cold, pale, or blue fingers/toes — severe vasoconstriction (notably NBOMe / DOx)
- Persistent vomiting; unconsciousness; uncontrollable agitation or risk of self-harm
What to do
- Stay calm and reassure — remind them they took a drug and the effect will pass
- Move to a calm, quiet, safe space with low light; reduce noise and sensory input
- Keep them from harm — they may act on fear or confusion; stay with them, don't leave them alone
- Talk them down gently; don't grab or restrain unless they're in danger
- For the medical signs above (overheating, seizure, chest pain, vasoconstriction, unresponsive) call emergency services
- If overheating, cool the body; be ready to give rescue breaths / CPR
The experience is time-limited and usually resolves with calm reassurance in a safe setting — psychological first aid, not medication. Serious physical harm is uncommon for classic psychedelics (LSD, psilocybin) but real for some potent phenethylamines (NBOMe, DOx), where hyperthermia, seizures, and vasoconstriction warrant emergency care.
988 Suicide & Crisis LifelineFireside Project: 62-FIRESIDE
References
- [1]^abBrandt SD, Kavanagh PV, Twamley B, Westphal F, Elliott SP, Wallach J, Stratford A, Klein LM, McCorvy JD, Nichols DE, Halberstadt AL (2018) Return of the lysergamides. Part IV: Analytical and pharmacological characterization of lysergic acid morpholide (LSM-775) — Drug Testing and Analysis doi:10.1002/dta.2222
- [2]^Halberstadt AL, Koedood L, Powell SB, Geyer MA (2011) Differential contributions of serotonin receptors to the behavioral effects of indoleamine hallucinogens in mice — Journal of Psychopharmacology doi:10.1177/0269881110388326
- [3]
- [4]^de la Fuente Revenga M, Jaster AM, McGinn J, Silva G, Saha S, Gonzalez-Maeso J (2022) Tolerance and Cross-Tolerance among Psychedelic and Nonpsychedelic 5-HT2A Receptor Agonists in Mice — ACS Chemical Neuroscience doi:10.1021/acschemneuro.2c00170